Definitive Contract 75N92020C00021
Award Date
8/28/20
Potential Completion Date
8/27/21
Potential Value
$6.6M
Federal Agency
National Heart Lung and Blood Institute
Awardee
Ceres Nanosciences, Inc.
Ultimate Awardee
Not listed
NAICS Category
334516 - Analytical Laboratory Instrument Manufacturing
PSC Category
Q301 - Reference Laboratory Testing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Manassas, VA 20110, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $9,600,000.00 firm fixed-price contract awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency, to Ceres Nanosciences, Inc. to develop a wastewater COVID-19 surveillance framework driven by public health authorities at the city, county, and state levels. The contract supports the Rapid Acceleration of Diagnostics (RADx) Tech - CERES program and does not have a set-aside designation. Ceres Nanosciences is a for-profit company that provides...
The U.S. Centers for Disease Control and Prevention (CDC) awarded a $78,048.30 firm fixed-price purchase order contract to Ceres Nanosciences, Inc., a for-profit organization based in Manassas, Virginia. The contract is for "Target-Capture Technology for Healthcare-Related Bacteria that are Prone to Carry Antimicrobial Resistant Genes." This award was not set aside. The contract has a period of performance through September 1, 2022. Ceres Nanosciences provides nanotechnology-enabled...
The National Institutes of Health's National Heart, Lung and Blood Institute awarded an $18.2 million firm fixed price definitive contract to Quanterix Corporation as part of the Rapid Acceleration of Diagnostics initiative. The RADx program aims to expedite the development, commercialization, and implementation of Covid-19 testing technologies to significantly increase domestic testing capacity. Quanterix will support this objective through the delivery of diagnostic solutions over a two-year...
The Department of Health and Human Services' National Institutes of Health National Heart Lung and Blood Institute awarded a $250,000 firm fixed price purchase order to Arete Biosciences, LLC of Chicago, Illinois. The contract is to support the Rapid Acceleration of Diagnostics (RADX) Program Technology effort through January 18, 2022. No major subcontractors or set aside designations were indicated. The award provides funding for Arete Biosciences to likely deliver diagnostic technologies or...
The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a firm fixed price purchase order contract to Ascella Biosystems Inc., a for-profit manufacturer, on January 13, 2021. The $250,000.00 contract is for RADX-TECH - SUPPORT SERVICES NEEDED FOR WORK PACKAGE 1 and is associated with the Coronavirus COVID-19 national interest action. The contract does not have a set-aside designation and is scheduled for completion on January...
This federal contract award, valued at $10,691,445.48, was issued by the National Heart Lung and Blood Institute, a civilian agency within the U.S. government, to the National Collegiate Inventors & Innovators Alliance, Inc. (doing business as Venturewell), a non-profit organization. The contract is for Rapid Acceleration of Diagnostics (RADx) Clinical Evaluation Services (CES) - Task Order 9. Venturewell has extensive experience managing federal contracts and grants focused on advancing...
This is a definitive contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a civilian agency within the National Institutes of Health (NIH), to the National Collegiate Inventors & Innovators Alliance, Inc. (doing business as Venturewell), a non-profit organization. The $33,379,628.30 firm fixed-price contract is for NHLBI's Rapid Acceleration of Diagnostics (RADx) initiative, providing ITAP consultants and infrastructure support. The contract has a period of...
The National Institutes of Health National Heart Lung and Blood Institute awarded a $15 million firm fixed price purchase order to National Collegiate Inventors & Innovators Alliance, Inc., doing business as Venturewell, for the Rapid Acceleration of Diagnostics (RADX) Initiative - Phase 0. As part of the RADX Initiative to accelerate the development, testing, and implementation of novel diagnostics for COVID-19, this contract will support Venturewell's efforts to advance diagnostics through...
This federal contract award was issued by the National Heart Lung and Blood Institute (NHLBI), a civilian agency within the National Institutes of Health (NIH), to the National Collegiate Inventors & Innovators Alliance, Inc. (doing business as Venturewell), a non-profit organization based in Hadley, Massachusetts. The $2,097,064.03 firm fixed-price delivery order is for clinical evaluation services in support of the Rapid Acceleration of Diagnostics (RADx) initiative, which aims to...
The National Institutes of Health National Heart Lung and Blood Institute awarded a $14.9 million purchase order contract to the National Collegiate Inventors & Innovators Alliance, Inc., doing business as Venturewell, to provide infrastructure support for the Rapid Acceleration of Diagnostics Initiative. The one-year, time and materials contract will support the NIH's RADX program, which aims to accelerate the development, commercialization, and implementation of novel diagnostics...